NO20032582L - 1,2,4-oksadiazolderivater som HPPAR alfa agonister - Google Patents

1,2,4-oksadiazolderivater som HPPAR alfa agonister

Info

Publication number
NO20032582L
NO20032582L NO20032582A NO20032582A NO20032582L NO 20032582 L NO20032582 L NO 20032582L NO 20032582 A NO20032582 A NO 20032582A NO 20032582 A NO20032582 A NO 20032582A NO 20032582 L NO20032582 L NO 20032582L
Authority
NO
Norway
Prior art keywords
oxadiazole derivatives
alpha agonists
hppar alpha
hppar
agonists
Prior art date
Application number
NO20032582A
Other languages
English (en)
Other versions
NO20032582D0 (no
Inventor
Kevin Guangcheng Liu
Francoise Jeanne Gellibert
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20032582D0 publication Critical patent/NO20032582D0/no
Publication of NO20032582L publication Critical patent/NO20032582L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20032582A 2000-12-08 2003-06-06 1,2,4-oksadiazolderivater som HPPAR alfa agonister NO20032582L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029974.3A GB0029974D0 (en) 2000-12-08 2000-12-08 Chemical compounds
PCT/GB2001/005400 WO2002046174A1 (en) 2000-12-08 2001-12-06 1, 2, 4-oxadiazole derivatives as hppar alpha agonists

Publications (2)

Publication Number Publication Date
NO20032582D0 NO20032582D0 (no) 2003-06-06
NO20032582L true NO20032582L (no) 2003-08-07

Family

ID=9904715

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032582A NO20032582L (no) 2000-12-08 2003-06-06 1,2,4-oksadiazolderivater som HPPAR alfa agonister

Country Status (13)

Country Link
US (1) US7141591B2 (no)
EP (1) EP1355890A1 (no)
AU (2) AU2002220902B2 (no)
CA (1) CA2430847A1 (no)
CZ (1) CZ20031581A3 (no)
GB (1) GB0029974D0 (no)
IL (2) IL156174A0 (no)
MX (1) MXPA03005008A (no)
NO (1) NO20032582L (no)
NZ (1) NZ526251A (no)
PL (1) PL360974A1 (no)
WO (1) WO2002046174A1 (no)
ZA (1) ZA200304312B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7205321B2 (en) 2001-11-15 2007-04-17 Eli Lilly And Company Peroxisome proliferator activated receptor alpha agonists
GB0214139D0 (en) * 2002-06-19 2002-07-31 Glaxo Group Ltd Chemical compounds
BR0312503A (pt) * 2002-07-09 2007-06-26 Bristol Myers Squibb Co derivados heterocìclicos substituìdos úteis como agentes antidiabéticos e antiobesidade, composição farmacêutica, uso e combinação dos mesmos
CA2549385A1 (en) 2003-12-22 2005-07-21 Eli Lilly And Company Triazole, oxadiazole and thiadiazole derivative as ppar modulators for the treatment of diabetes
JP5069813B2 (ja) * 2010-10-14 2012-11-07 第一三共株式会社 アシルベンゼン誘導体
PH12014500251A1 (en) * 2011-07-29 2014-03-17 Daiichi Sankyo Co Ltd N-hetero-ring-substituted amide derivative
IN2014MN01442A (no) * 2012-01-18 2015-07-03 Daiichi Sankyo Co Ltd

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE292622T1 (de) * 1997-01-22 2005-04-15 Aventis Pharma Inc Substituierte beta-thiocarbonsäuren
PL351470A1 (en) 1999-04-28 2003-04-22 Aventis Pharma Gmbh Tri-aryl acid derivatives as ppar receptor ligands
US6417212B1 (en) 1999-08-27 2002-07-09 Eli Lilly & Company Modulators of peroxisome proliferator activated receptors
US6875780B2 (en) * 2002-04-05 2005-04-05 Warner-Lambert Company Compounds that modulate PPAR activity and methods for their preparation

Also Published As

Publication number Publication date
NO20032582D0 (no) 2003-06-06
US20040132787A1 (en) 2004-07-08
WO2002046174A1 (en) 2002-06-13
MXPA03005008A (es) 2003-09-05
IL156174A0 (en) 2003-12-23
IL156174A (en) 2008-11-03
ZA200304312B (en) 2004-10-13
CZ20031581A3 (cs) 2003-08-13
GB0029974D0 (en) 2001-01-24
AU2090202A (en) 2002-06-18
NZ526251A (en) 2006-03-31
EP1355890A1 (en) 2003-10-29
US7141591B2 (en) 2006-11-28
CA2430847A1 (en) 2002-06-13
AU2002220902B2 (en) 2005-06-02
PL360974A1 (en) 2004-09-20

Similar Documents

Publication Publication Date Title
NO20030929L (no) Guanidinobenzamider som MC4-R agonister
NO20041560L (no) 1,6-nafthyridinderivater som antidiabetiske midler
DK1379522T3 (da) Dihydro-benzo(b)(1,4)diazeping-2-on-derivater som MGLUR2-antagonister I
NO20044654L (no) Piperidinoylpiperidiner som 5-HTIF-agonister
DK1244642T3 (da) Substituerede oxazol- og thiazolderivater som HPPAR-alfa-aktivatorer
EP1555267A4 (en) 2,3-dihydro-6-NITROIMIDAZOç2,1-b] oxazoles
DK1446394T3 (da) Hidtil ukendte 1,2,4-thiadiazolderivater som melanocortinreceptormodulatorer
NO20052993D0 (no) 4,5-diaryltiazolderivater som CB-1 ligander.
DK1442030T3 (da) Thiopen- og thiazolsulfonamider som antineoplastiske midler
DK1339685T3 (da) Biphenylcarboxamider, der er egnede som lipidsænkende midler
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
BR0300119B1 (pt) composiÇço aquosa.
NO20033700D0 (no) Isoksazolinderivater som anti-depressive midler
NO20032582D0 (no) 1,2,4-oksadiazolderivater som HPPAR alfa agonister
DE60315471D1 (de) 2,5-disubstituierte 3-mercaptopentansaure
NO20022379D0 (no) Nye tiazolidinedionderivater som antidiabetiske midler
DK1532141T3 (da) 2-pyrrolidin-2-yl-[1,3,4]-oxadiazol-derivater og anvendelse deraf som antidepressiv
NO20044413L (no) 1,2-Dihydropyrazol-3-oner som cytokinmediatorer
NO20044405L (no) Neurotensinaktive 2,3-diaryl-pyrazolidin derivater
DE60140939D1 (de) Nd darin verwendete zusammensetzung
NO20031239L (no) 1-amino-alkylsykloheksaner som trypanocidale midler
HK1061393A (en) 1,2,4-oxadiazole derivatives as hppar alpha agonists
NO20053110D0 (no) 2-oksyamino-1-cyklopenten-1-nitriler som materialbeskyttelsesmidler.
IS7131A (is) Nýjar 2,4-díamínóþíasól afleiður
RU2000116332A (ru) Антгельминтное средство

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
FC2A Withdrawal, rejection or dismissal of laid open patent application